$20.59
À la fermeture: Oct 3, 5:08 PM EDT
$20.21
-0.38-1.85%
Pré-commercialisation: Oct 3, 5:08 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Seres Therapeutics Inc (NASDAQ:MCRB) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 1.01M à 936.25K. Cela représente 17.38% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Seres Therapeutics Corp (XNAS:MCRB) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 378.63K actions échangées par jour, il faudrait 2.47 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
936.25K
Intérêt à court terme %
17.4%
Jours de couverture
2.47
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. Commo | 09/15/2025 | 09/24/2025 | 17.38% | 5,386,414 | 936,245 | 378,634 | 2.47 | |
MCRB | Seres Therapeutics, Inc. Commo | 08/29/2025 | 09/10/2025 | 18.79% | 5,386,414 | 1,012,144 | 117,506 | 8.61 | |
MCRB | Seres Therapeutics, Inc. Commo | 08/15/2025 | 08/26/2025 | 19.20% | 5,386,414 | 1,034,377 | 122,470 | 8.45 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/31/2025 | 08/11/2025 | 18.65% | 5,386,414 | 1,004,423 | 126,313 | 7.95 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/15/2025 | 07/24/2025 | 16.05% | 5,364,266 | 861,106 | 175,216 | 4.91 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/30/2025 | 07/10/2025 | 12.92% | 5,364,266 | 693,134 | 120,771 | 5.74 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/13/2025 | 06/25/2025 | 12.67% | 5,364,266 | 679,397 | 81,335 | 8.35 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/30/2025 | 06/10/2025 | 13.26% | 5,364,266 | 711,221 | 69,141 | 10.29 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/15/2025 | 05/27/2025 | 14.89% | 5,364,266 | 798,969 | 108,120 | 7.39 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/30/2025 | 05/09/2025 | 11.41% | 5,349,781 | 610,359 | 202,886 | 3.01 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/15/2025 | 04/25/2025 | — | 5,349,781 | 15,262,138 | 1,276,585 | 11.96 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/31/2025 | 04/09/2025 | 14.96% | 106,995,642 | 16,010,235 | 812,899 | 19.7 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/14/2025 | 03/25/2025 | 15.63% | 106,995,642 | 16,718,590 | 908,601 | 18.4 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/28/2025 | 03/11/2025 | 13.51% | 127,569,892 | 17,234,746 | 711,413 | 24.23 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/14/2025 | 02/26/2025 | 13.87% | 127,569,892 | 17,694,032 | 784,322 | 22.56 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/31/2025 | 02/11/2025 | 13.68% | 127,569,892 | 17,456,803 | 2,989,948 | 5.84 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/15/2025 | 01/27/2025 | 15.88% | 127,569,892 | 20,261,193 | 1,298,346 | 15.61 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/31/2024 | 01/10/2025 | 16.02% | 127,569,892 | 20,440,169 | 1,890,611 | 10.81 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/13/2024 | 12/24/2024 | 15.37% | 127,569,892 | 19,613,483 | 3,038,507 | 6.45 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/29/2024 | 12/10/2024 | 13.63% | 127,569,892 | 17,381,399 | 4,495,587 | 3.87 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/15/2024 | 11/26/2024 | 12.73% | 127,569,892 | 16,235,306 | 2,512,081 | 6.46 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/31/2024 | 11/11/2024 | 14.05% | 127,032,076 | 17,852,612 | 1,872,282 | 9.54 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/15/2024 | 10/24/2024 | 14.21% | 127,032,076 | 18,054,013 | 3,957,489 | 4.56 | |
MCRB | Seres Therapeutics, Inc. Commo | 09/30/2024 | 10/09/2024 | 14.69% | 127,032,076 | 18,656,453 | 6,219,924 | 3 | |
MCRB | Seres Therapeutics, Inc. Commo | 09/13/2024 | 09/24/2024 | 15.76% | 109,213,562 | 17,215,115 | 5,850,328 | 2.94 | |
MCRB | Seres Therapeutics, Inc. Commo | 08/30/2024 | 09/11/2024 | 14.60% | 109,213,562 | 15,940,210 | 1,520,212 | 10.49 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/31/2024 | 08/09/2024 | 15.12% | 108,249,112 | 16,362,258 | 4,477,804 | 3.65 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/15/2024 | 07/24/2024 | 15.71% | 108,249,112 | 17,001,853 | 3,734,284 | 4.55 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/28/2024 | 07/10/2024 | 19.11% | 108,249,112 | 20,686,202 | 3,336,807 | 6.2 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/14/2024 | 06/26/2024 | 21.11% | 108,249,112 | 22,849,640 | 6,618,838 | 3.45 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/31/2024 | 06/11/2024 | 20.87% | 108,249,112 | 22,596,209 | 2,131,124 | 10.6 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/15/2024 | 05/24/2024 | 21.00% | 108,249,112 | 22,737,212 | 6,683,307 | 3.4 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/30/2024 | 05/09/2024 | 19.83% | 108,249,112 | 21,462,357 | 5,832,690 | 3.68 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/15/2024 | 04/24/2024 | 16.36% | 107,810,811 | 17,634,355 | 4,188,886 | 4.21 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/28/2024 | 04/09/2024 | 17.44% | 107,810,811 | 18,803,257 | 3,023,809 | 6.22 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/15/2024 | 03/26/2024 | 17.06% | 107,810,811 | 18,397,627 | 5,742,326 | 3.2 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/29/2024 | 03/11/2024 | 14.94% | 107,810,811 | 16,104,377 | 3,939,656 | 4.09 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/15/2024 | 02/27/2024 | 22.69% | 68,728,747 | 15,591,918 | 2,538,032 | 6.14 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/31/2024 | 02/09/2024 | 22.68% | 68,728,747 | 15,590,248 | 4,144,008 | 3.76 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/12/2024 | 01/24/2024 | 25.54% | 68,728,747 | 17,553,318 | 8,840,617 | 1.99 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/29/2023 | 01/10/2024 | 23.68% | 68,728,747 | 16,277,554 | 4,138,787 | 3.93 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/15/2023 | 12/27/2023 | 30.28% | 68,728,747 | 20,814,217 | 4,635,859 | 4.49 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/30/2023 | 12/11/2023 | 30.49% | 68,728,747 | 20,953,327 | 3,702,243 | 5.66 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/15/2023 | 11/27/2023 | 34.00% | 68,728,747 | 23,369,313 | 6,824,952 | 3.42 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/31/2023 | 11/09/2023 | 33.62% | 68,728,747 | 23,104,830 | 3,011,984 | 7.67 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/13/2023 | 10/24/2023 | 33.77% | 67,676,162 | 22,854,391 | 2,821,623 | 8.1 | |
MCRB | Seres Therapeutics, Inc. Commo | 09/29/2023 | 10/10/2023 | 31.28% | 67,676,162 | 21,172,091 | 2,321,730 | 9.12 |
À la recherche des actions les plus vendues à découvert?